Literature DB >> 16943564

Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.

Latha Devi1, Badanavalu M Prabhu, Domenico F Galati, Narayan G Avadhani, Hindupur K Anandatheerthavarada.   

Abstract

Mitochondrial dysfunction is one of the major intracellular lesions of Alzheimer's disease (AD). However, the causative factors involved in the mitochondrial dysfunction in human AD are not well understood. Here we report that nonglycosylated full-length and C-terminal truncated amyloid precursor protein (APP) accumulates exclusively in the protein import channels of mitochondria of human AD brains but not in age-matched controls. Furthermore, in AD brains, mitochondrially associated APP formed stable approximately 480 kDa complexes with the translocase of the outer mitochondrial membrane 40 (TOM40) import channel and a super complex of approximately 620 kDa with both mitochondrial TOM40 and the translocase of the inner mitochondrial membrane 23 (TIM23) import channel TIM23 in an "N(in mitochondria)-C(out cytoplasm)" orientation. Accumulation of APP across mitochondrial import channels, which varied with the severity of AD, inhibited the entry of nuclear-encoded cytochrome c oxidase subunits IV and Vb proteins, which was associated with decreased cytochrome c oxidase activity and increased levels of H2O2. Regional distribution of mitochondrial APP showed higher levels in AD-vulnerable brain regions, such as the frontal cortex, hippocampus, and amygdala. Mitochondrial accumulation of APP was also observed in the cholinergic, dopaminergic, GABAergic, and glutamatergic neuronal types in the category III AD brains. The levels of translocationally arrested mitochondrial APP directly correlated with mitochondrial dysfunction. Moreover, apolipoprotein genotype analysis revealed that AD subjects with the E3/E4 alleles had the highest content of mitochondrial APP. Collectively, these results suggest that abnormal accumulation of APP across mitochondrial import channels, causing mitochondrial dysfunction, is a hallmark of human AD pathology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943564      PMCID: PMC6675337          DOI: 10.1523/JNEUROSCI.1469-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Effects of learning on cytochrome oxidase activity in cuttlefish brain.

Authors:  V Agin; R Chicher; M P Chichery
Journal:  Neuroreport       Date:  2001-01-22       Impact factor: 1.837

2.  A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.

Authors:  I Maurer; S Zierz; H J Möller
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

3.  Tissue variant effects of heme inhibitors on the mouse cytochrome c oxidase gene expression and catalytic activity of the enzyme complex.

Authors:  C Vijayasarathy; S Damle; N Lenka; N G Avadhani
Journal:  Eur J Biochem       Date:  1999-11

Review 4.  Translating cell biology into therapeutic advances in Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

5.  The TIM17.23 preprotein translocase of mitochondria: composition and function in protein transport into the matrix.

Authors:  F Moro; C Sirrenberg; H C Schneider; W Neupert; M Brunner
Journal:  EMBO J       Date:  1999-07-01       Impact factor: 11.598

6.  Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts.

Authors:  A Cedazo-Mínguez; B Wiehager; B Winblad; M Hüttinger; R F Cowburn
Journal:  Neurochem Int       Date:  2001-06       Impact factor: 3.921

7.  Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.

Authors:  G E Gibson; V Haroutunian; H Zhang; L C Park; Q Shi; M Lesser; R C Mohs; R K Sheu; J P Blass
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

8.  Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration.

Authors:  W Duan; V M Rangnekar; M P Mattson
Journal:  J Neurochem       Date:  1999-06       Impact factor: 5.372

9.  Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at ser128.

Authors:  H K Anandatheerthavarada; G Biswas; J Mullick; N B Sepuri; L Otvos; D Pain; N G Avadhani
Journal:  EMBO J       Date:  1999-10-15       Impact factor: 11.598

Review 10.  The cholinergic hypothesis of Alzheimer's disease: a review of progress.

Authors:  P T Francis; A M Palmer; M Snape; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

View more
  324 in total

Review 1.  An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.

Authors:  Allen D Roses
Journal:  Arch Neurol       Date:  2010-05

2.  Substrate specificity of the TIM22 mitochondrial import pathway revealed with small molecule inhibitor of protein translocation.

Authors:  Samuel A Hasson; Robert Damoiseaux; Jenny D Glavin; Deepa V Dabir; Scott S Walker; Carla M Koehler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

3.  Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity.

Authors:  Lila K Habib; Michelle T C Lee; Jerry Yang
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

4.  Molecular genetics of a patient with Mohr-Tranebjaerg Syndrome due to a new mutation in the DDP1 gene.

Authors:  José Rafael Blesa; Abelardo Solano; Paz Briones; Jesús Angel Prieto-Ruiz; José Hernández-Yago; Francisco Coria
Journal:  Neuromolecular Med       Date:  2007-08-03       Impact factor: 3.843

5.  Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction.

Authors:  So Jung Park; Ji Hyun Shin; Jae In Jeong; Ji Hoon Song; Yoon Kyung Jo; Eun Sung Kim; Eunjoo H Lee; Jung Jin Hwang; Eun Kyung Lee; Sun Ju Chung; Jae-Young Koh; Dong-Gyu Jo; Dong-Hyung Cho
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

Review 6.  Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity.

Authors:  Roberto Cappai; Kevin J Barnham
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

7.  Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.

Authors:  Koteswara R Valasani; Gang Hu; Michael O Chaney; Shirley S Yan
Journal:  Chem Biol Drug Des       Date:  2012-11-14       Impact factor: 2.817

8.  Epoxyeicosatrienoic acids pretreatment improves amyloid β-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes.

Authors:  Pallabi Sarkar; Ivan Zaja; Martin Bienengraeber; Kevin R Rarick; Maia Terashvili; Scott Canfield; John R Falck; David R Harder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

9.  Mitochondrial bioenergetics is defective in presymptomatic Tg2576 AD mice.

Authors:  Merina Varghese; Wei Zhao; Jun Wang; Alice Cheng; Xianjuan Qian; Amna Chaudhry; Lap Ho; Giulio Maria Pasinetti
Journal:  Transl Neurosci       Date:  2011-03-01       Impact factor: 1.757

10.  Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease.

Authors:  Yongfu Wang; Long Wu; Jianping Li; Du Fang; Changjia Zhong; John Xi Chen; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.